688217实控人被起诉

Core Viewpoint - Ruiang Gene's actual controllers, Xiong Hui and Xiong Jun, are facing legal action for fraud, which has been officially filed by the prosecution [2][4]. Group 1: Legal Issues - Ruiang Gene announced that its actual controllers, Xiong Hui and Xiong Jun, have been sued for fraud by the prosecution [2]. - Both individuals were previously detained and are now facing formal charges [4]. - The company stated that Xiong Hui and Xiong Jun do not hold any current positions as directors or senior management, and this situation is not expected to significantly impact the company's daily operations [4]. Group 2: Company Management Changes - Gao Shangxian has taken over as chairman and general manager, succeeding Xiong Hui, who is his spouse [4]. - The actual controllers of Ruiang Gene include Xiong Hui, Gao Shangxian, Xiong Jun, and Gao Ze, collectively holding 30.62% of the company's shares [5][6]. Group 3: Financial Performance - Ruiang Gene reported a net loss of 15.76 million yuan in 2024, a decrease of 298.78% compared to the previous year [6][7]. - The company anticipates a further net loss for 2025, estimated between 39.91 million yuan and 59.86 million yuan [6]. - The decline in revenue is attributed to intensified competition in the in vitro diagnostics industry, slower customer payments, and the suspension of certain projects [7].